News
Cambridge-based Biogen is looking to the growth of its Alzheimer’s drug Leqembi to offset the decline of its multiple ...
Biotech company Biogen (NASDAQ:BIIB) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 7.3% year on year to ...
ImmunityBio (IBRX) stock gains as its CAR-NK cell therapy shows promise in an early stage trial, with lymphoma patients ...
Stoke Therapeutics and Biogen have begun dosing in the global Phase III EMPEROR study of zorevunersen for Dravet syndrome, ...
StockStory.org on MSN6h
5 Insightful Analyst Questions From Supernus Pharmaceuticals’s Q2 Earnings Call
Supernus Pharmaceuticals delivered a quarter that saw revenue surpass Wall Street’s expectations, despite a year-over-year ...
Cambridge, Massachusetts Wednesday, August 13, 2025, 15:00 Hrs [IST] ...
Ready to get scared? Edmonton’s iconic Deadmonton Haunted House has revealed its 2025 themes — and they’ll send chills down ...
How to get rich? The single best way is to live a long time, ideally working much of that time while amassing savings that ...
Calm prevailed across Wall Street as an in-line inflation reading bolstered speculation the Federal Reserve will have room to ...
Cannabinoids are specific chemical compounds found in cannabis, such as tetrahydrocannabinol (THC) and cannabidiol (CBD). Research is increasingly su ...
Brinsupri, which Insmed acquired from AstraZeneca nearly a decade ago, is the first treatment for bronchiectasis that’s not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results